Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$13.49 – $17.30
13% from low
Exchange
OTC Link
OS
CELLAVISION AB ORD
No one on the platform currently holds CLVSF.
No tracked institution reports a position in CLVSF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-30 | $2.7500 | 2026-05-06 |
| 2025-05-08 | $2.5000 | 2025-05-13 |
| 2024-05-06 | $2.2500 | 2024-05-13 |
No one on the platform has traded CLVSF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $783M | +4.2% | $5.89 | $5.72–$6.11 | 2.4× | 1 |
| 2027 | $879M | +12.2% | $7.39 | $7.17–$7.67 | 1.9× | 1 |
| 2028 | $955M | +8.6% | $8.38 | $8.13–$8.70 | 1.7× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-17 | $0.14 | $0.14 | +2.3% |
| 2026-04-24 | $0.16 | $0.10 | -39.1% |
| 2026-02-05 | $0.14 | $0.19 | +37.3% |
| 2025-11-05 | $0.11 | $0.14 | +24.4% |
| 2025-07-17 | $0.17 | $0.16 | -4.8% |
| 2025-05-02 | $0.14 | $0.17 | +26.9% |
| 2025-02-06 | $0.17 | $0.15 | -9.1% |
| 2024-10-24 | $0.17 | $0.13 | -22.3% |
| +0.00% |
| $428M |
| — |
| FDMDF4DMedical Limited | $2.40 | -2.04% | $1.4B | — |
| GSGTFGenSight Biologics S.A. | $0.09 | +0.00% | $15M | — |
Source: Financial Modeling Prep · peers by sector/industry